Figure 1

Experimental and data analysis workflow for applying omics to drug-drug interactions. (A) The overall design of the study. (B) Further details of 2 specific procedures indicated with broken-lined boxes in A. The black, blue and orange bars represent untreated, single treatment and combined treatment, respectively.